Development of a prognostic pyroptosis-related gene signature for head and neck squamous cell carcinoma patient.

Overall, these results highlight a novel prognostic gene signature that offers value in the context of HNSCC patient evaluation, although additional research will be essential to elucidate the mechanisms linking these PRGs to HNSCC outcomes.